Lars Fugger

Active 1989–2025

82
Papers
21,487
Citations
67
h-index
82
i10-index

Citations

Citations per year for Lars Fugger1977: 1 citations1983: 1 citations1987: 1 citations1990: 1 citations1991: 3 citations1992: 2 citations1993: 4 citations1994: 20 citations1995: 24 citations1996: 34 citations1997: 35 citations1998: 54 citations1999: 65 citations2000: 68 citations2001: 50 citations2002: 83 citations2003: 73 citations2004: 94 citations2005: 112 citations2006: 83 citations2007: 106 citations2008: 140 citations2009: 174 citations2010: 161 citations2011: 152 citations2012: 163 citations2013: 172 citations2014: 179 citations2015: 171 citations2016: 140 citations2017: 170 citations2018: 314 citations2019: 677 citations2020: 792 citations2021: 827 citations2022: 703 citations2023: 596 citations2024: 902 citations2025: 429 citations2026: 36 citations1978–1982: no citations, so these years are not shown1984–1986: no citations, so these years are not shown1988–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,944 citing papers, 24.9% of this breakdownUnited Kingdom: 1,033 citing papers, 8.7% of this breakdownGermany: 942 citing papers, 8% of this breakdownChina: 845 citing papers, 7.1% of this breakdownItaly: 498 citing papers, 4.2% of this breakdownAustralia: 438 citing papers, 3.7% of this breakdownCanada: 429 citing papers, 3.6% of this breakdownFrance: 396 citing papers, 3.3% of this breakdownNetherlands: 351 citing papers, 3% of this breakdownSwitzerland: 350 citing papers, 3% of this breakdownSweden: 318 citing papers, 2.7% of this breakdownSpain: 269 citing papers, 2.3% of this breakdown
0%24.9%Other 25.5%

Fields

  • Medicine35.1%
  • Biochemistry, Genetics and Molecular Biology34.3%
  • Immunology and Microbiology17.4%
  • Neuroscience10.3%
  • Computer Science0.5%
  • Agricultural and Biological Sciences0.4%
  • Other2%

Topics

  • T-cell and B-cell Immunology5.3%
  • Multiple Sclerosis Research Studies5%
  • Single-cell and spatial transcriptomics4.9%
  • Immune Cell Function and Interaction4%
  • Immunotherapy and Immune Responses3.4%
  • Neuroinflammation and Neurodegeneration Mechanisms3.1%
  • Other74.3%

Coauthors

All papers

Open in search
  1. The Human Cell Atlas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John C Marioni, Miriam Merad, Musa Mhlanga, Martijn Nawijn, Mihai Netea, Garry Nolan, Dana Pe'er, Anthony Phillipakis, Chris P Ponting, Stephen Quake, Wolf Reik, Orit Rozenblatt-Rosen, Joshua Sanes, Rahul Satija, Ton N Schumacher, Alex Shalek, Ehud Shapiro, Padmanee Sharma, Jay W Shin, Oliver Stegle, Michael Stratton, Michael J T Stubbington, Fabian J Theis, Matthias Uhlen, Alexander van Oudenaarden, Allon Wagner, Fiona Watt, Jonathan Weissman, Barbara Wold, Ramnik Xavier, Nir Yosef, Human Cell Atlas Meeting Participants - eLife 2017 cited by 2,352

  2. Immunopathology of multiple sclerosis

    Authors: , , - Nature reviews. Immunology 2015 cited by 2,213

  3. Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases

    Authors: , , - Cell 2020 cited by 400

  4. The immunology of multiple sclerosis

    Authors: , , , , - Nature reviews. Immunology 2022 cited by 340

  5. HLA variation and disease

    Authors: , , , - Nature reviews. Immunology 2018 cited by 826

  6. Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eske Willerslev - Nature 2024 cited by 136

  7. Identification of early neurodegenerative pathways in progressive multiple sclerosis

    Authors: , , , , , , , , , , , , , , , , , , - Nature Neuroscience 2022 cited by 127

  8. The selection landscape and genetic legacy of ancient Eurasians

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Sikora, Rasmus Nielsen, Fernando Racimo, Eske Willerslev - Nature 2024 cited by 139

  9. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis

    Authors: , , - Nature Reviews Neurology 2014 cited by 628

  10. Inflammation-related plasma and CSF biomarkers for multiple sclerosis

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 197

  11. Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis

    Authors: , , , , , , - American Journal Of Pathology 2007 cited by 1,177

  12. A functional and structural basis for TCR cross-reactivity in multiple sclerosis

    Authors: , , , , , , , , , , , , , - Nature Immunology 2002 cited by 594

  13. Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitors

    Authors: , , , - EBioMedicine 2023 cited by 73

  14. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease

    Authors: , , , , , , , , , , , , - Nature Medicine 1998 cited by 1,179

  15. Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2016 cited by 260

  16. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aimée L Fenwick, Jonathan Flint, Lars Fugger, Rodney D. Gilbert, Anne Goriely, Angie Green, Ingo H. Greger, Russell Grocock, Anja V. Gruszczyk, Robert Hastings, Edouard Hatton, Douglas R. Higgs, Adrian V. S. Hill, Chris Holmes, Malcolm F. Howard, Linda Hughes, Peter Humburg, David H. Johnson, Fredrik Karpe, Zoya Kingsbury, Usha Kini, Julian C. Knight, Jonathan Krohn, Sarah Lamble, Craig B. Langman, Lorne Lonie, Joshua Luck, Davis J. McCarthy, Simon J. McGowan, Mary Frances McMullin, Kerry A. Miller, Lisa Murray, Andrea H. Németh, M. Andrew Nesbit, David Nutt, Elizabeth Ormondroyd, Annette Oturai, Alistair T. Pagnamenta, Smita Y. Patel, Melanie J. Percy, Nayia Petousi, Paolo Piazza, Siân E. Piret, Guadalupe Polanco‐Echeverry, Niko Popitsch, Fiona Powrie, Christopher W. Pugh, Lynn Quek, Peter A. Robbins, Kathryn Robson, Alexandra Russo, Natasha Sahgal, Pauline A. van Schouwenburg, Anna Schuh, Earl D. Silverman, Alison Simmons, Per Soelberg Sørensen, Elizabeth Sweeney, John Taylor, Rajesh V. Thakker, Ian Tomlinson, Amy Trebes, Stephen R.F. Twigg, Holm H. Uhlig, Paresh Vyas, Tim J. Vyse, Steven A. Wall, Hugh Watkins, Michael P. Whyte, Lorna Witty and 10 more - Nature Genetics 2015 cited by 388

  17. Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis

    Authors: , , , , , , , , , , - Med 2021 cited by 95

  18. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 383

  19. Constitutively Active Lck Kinase in T Cells Drives Antigen Receptor Signal Transduction

    Authors: , , , , , , , , , , , , - Immunity 2010 cited by 350

  20. Activation of Central Orexin/Hypocretin Neurons by Dietary Amino Acids

    Authors: , , , , , , - Neuron 2011 cited by 169

  21. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor

    Authors: , , , , , , , , , , , - Nature Genetics 1999 cited by 334

  22. Inhibitory Interplay between Orexin Neurons and Eating

    Authors: , , , , , - Current Biology 2016 cited by 159

  23. Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ana Mafalda Santos, Steven F. Lee, Richard J. Cornall, David Klenerman, Simon J. Davis - Immunity 2024 cited by 34

  24. Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system

    Authors: , , , , , , , - Nature Medicine 2007 cited by 406